Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Clinical trials update 2015: Year in review.

Peroutka SJ.

Headache. 2016 Jan;56(1):178-84. doi: 10.1111/head.12744. Epub 2015 Dec 21. Review.

PMID:
26790852
2.

Clinical trials update 2014: year in review.

Peroutka SJ.

Headache. 2015 Jan;55(1):149-57. doi: 10.1111/head.12479. Epub 2014 Dec 19. Review.

PMID:
25522893
3.

What turns on a migraine? A systematic review of migraine precipitating factors.

Peroutka SJ.

Curr Pain Headache Rep. 2014 Oct;18(10):454. doi: 10.1007/s11916-014-0454-z. Review.

PMID:
25160711
4.

Calcitonin gene-related peptide targeted immunotherapy for migraine: progress and challenges in treating headache.

Peroutka SJ.

BioDrugs. 2014 Jun;28(3):237-44. doi: 10.1007/s40259-014-0083-4. Review.

PMID:
24452707
5.

Clinical trials update. 2013: year in review.

Peroutka SJ.

Headache. 2014 Jan;54(1):189-94. doi: 10.1111/head.12267. Epub 2013 Nov 21. Review.

PMID:
24400767
6.

Not all CGRP antagonists are created equal.

Peroutka SJ.

Headache. 2013 Jun;53(6):1004-6. doi: 10.1111/head.12107. No abstract available.

PMID:
23721243
7.

2011: year in review.

Peroutka SJ.

Headache. 2012 Jan;52(1):168-72. doi: 10.1111/j.1526-4610.2011.02084.x. Review. No abstract available.

PMID:
22268779
8.

2010: year in review.

Peroutka SJ.

Headache. 2011 Jan;51(1):181-7. doi: 10.1111/j.1526-4610.2010.01815.x.

PMID:
21198581
9.

2008: the year in review.

Peroutka SJ.

Headache. 2009 May;49(5):796-802. doi: 10.1111/j.1526-4610.2009.01422.x. Review. No abstract available.

PMID:
19456894
10.

Neurogenic inflammation and migraine: implications for the therapeutics.

Peroutka SJ.

Mol Interv. 2005 Oct;5(5):304-11. Review.

PMID:
16249526
11.

Analgesic safety and efficacy of diclofenac sodium softgels on postoperative third molar extraction pain.

Zuniga JR, Phillips CL, Shugars D, Lyon JA, Peroutka SJ, Swarbrick J, Bon C.

J Oral Maxillofac Surg. 2004 Jul;62(7):806-15.

PMID:
15218558
12.

Re: a sympathetic view of "2003 Wolff Award: possible parasympathetic contributions to peripheral and central sensitization during migraine".

Peroutka SJ.

Headache. 2004 Jul-Aug;44(7):731-2; author reply 732-3. No abstract available.

PMID:
15209704
13.

Migraine: a chronic sympathetic nervous system disorder.

Peroutka SJ.

Headache. 2004 Jan;44(1):53-64. Review.

PMID:
14979884
14.

Efficacy of diclofenac sodium softgel 100 mg with or without caffeine 100 mg in migraine without aura: a randomized, double-blind, crossover study.

Peroutka SJ, Lyon JA, Swarbrick J, Lipton RB, Kolodner K, Goldstein J.

Headache. 2004 Feb;44(2):136-41.

PMID:
14756851
15.

Sympathetic look at genetic basis of migraine.

Peroutka SJ.

Headache. 2002 May;42(5):378-81. No abstract available.

PMID:
12047340
16.

Serum glucose regulation and headache.

Peroutka SJ.

Headache. 2002 Apr;42(4):303-8. No abstract available.

PMID:
12010391
17.

Glucose regulation in headache: implications for dietary management.

Hufnagl KN, Peroutka SJ.

Expert Rev Neurother. 2002 May;2(3):311-7. doi: 10.1586/14737175.2.3.311.

PMID:
19810862
18.

Migraine with aura susceptibility locus on chromosome 19p13 is distinct from the familial hemiplegic migraine locus.

Jones KW, Ehm MG, Pericak-Vance MA, Haines JL, Boyd PR, Peroutka SJ.

Genomics. 2001 Dec;78(3):150-4.

PMID:
11735221
19.

Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine.

McCarthy LC, Hosford DA, Riley JH, Bird MI, White NJ, Hewett DR, Peroutka SJ, Griffiths LR, Boyd PR, Lea RA, Bhatti SM, Hosking LK, Hood CM, Jones KW, Handley AR, Rallan R, Lewis KF, Yeo AJ, Williams PM, Priest RC, Khan P, Donnelly C, Lumsden SM, O'Sullivan J, See CG, Smart DH, Shaw-Hawkins S, Patel J, Langrish TC, Feniuk W, Knowles RG, Thomas M, Libri V, Montgomery DS, Manasco PK, Xu CF, Dykes C, Humphrey PP, Roses AD, Purvis IJ.

Genomics. 2001 Dec;78(3):135-49. Erratum in: Genomics 2002 Feb;79(2):271.

PMID:
11735220
20.

Analysis of Internet sites for headache.

Peroutka SJ.

Cephalalgia. 2001 Feb;21(1):20-4.

PMID:
11298659
21.

The value of genotyping for apolipoprotein E alleles in relation to vitamin E supplementation.

Peroutka SJ, Dreon DM.

Eur J Pharmacol. 2000 Dec 27;410(2-3):161-163. Review.

PMID:
11134667
22.

Serotonin receptor variants in disease: new therapeutic opportunities?

Peroutka SJ.

Ann N Y Acad Sci. 1998 Dec 15;861:16-25. Review.

PMID:
9928234
23.

Chronic fatigue disorders: an inappropriate response to arginine vasopressin?

Peroutka SJ.

Med Hypotheses. 1998 Jun;50(6):521-3.

PMID:
9710328
24.

Step-wise analysis of polymorphisms in the human dopamine D2 receptor gene.

Jones KW, Peroutka SJ.

Neuropharmacology. 1998 Jun;37(6):803-14.

PMID:
9707294
25.
26.

Genetic basis of migraine.

Peroutka SJ.

Clin Neurosci. 1998;5(1):34-7. Review.

PMID:
9523056
27.
28.

Beyond monotherapy: rational polytherapy in migraine.

Peroutka SJ.

Headache. 1998 Jan;38(1):18-22.

PMID:
9504998
29.
30.

5-Hydroxytryptamine receptor subtype messenger RNAs in human dorsal root ganglia: a polymerase chain reaction study.

Pierce PA, Xie GX, Meuser T, Peroutka SJ.

Neuroscience. 1997 Dec;81(3):813-9.

PMID:
9316030
31.

Dopamine and migraine.

Peroutka SJ.

Neurology. 1997 Sep;49(3):650-6. Review.

PMID:
9305317
32.

Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles.

Peroutka SJ, Wilhoit T, Jones K.

Neurology. 1997 Jul;49(1):201-6.

PMID:
9222191
33.
34.

5-HT1D receptor agonist properties of novel 2-[5-[[(trifluoromethyl)sulfonyl]oxy]indolyl]ethylamines and their use as synthetic intermediates.

Barf TA, de Boer P, Wikström H, Peroutka SJ, Swensson K, Ennis MD, Ghazal NB, McGuire JC, Smith MW.

J Med Chem. 1996 Nov 22;39(24):4717-26.

PMID:
8941384
35.

Dual effect of the serotonin agonist, sumatriptan, on peripheral neurogenic inflammation.

Pierce PA, Xie GX, Peroutka SJ, Levine JD.

Reg Anesth. 1996 May-Jun;21(3):219-25.

PMID:
8744664
36.

Families linked and unlinked to chromosome 19 with familial hemiplegic migraine.

Peroutka SJ.

Cephalalgia. 1996 May;16(3):138. No abstract available.

PMID:
8734764
37.

Exclusion of 5-HT2A and 5-HT2C receptor genes as candidate genes for migraine.

Buchwalder A, Welch SK, Peroutka SJ.

Headache. 1996 Apr;36(4):254-8.

PMID:
8675433
38.
39.

Familial hemiplegic migraine, nystagmus, and cerebellar atrophy.

Elliott MA, Peroutka SJ, Welch S, May EF.

Ann Neurol. 1996 Jan;39(1):100-6.

PMID:
8572654
40.

5-Hydroxytryptamine-induced synovial plasma extravasation is mediated via 5-hydroxytryptamine2A receptors on sympathetic efferent terminals.

Pierce PA, Xie GX, Peroutka SJ, Green PG, Levine JD.

J Pharmacol Exp Ther. 1995 Oct;275(1):502-8.

PMID:
7562592
41.

The third intracellular loop of the 5-hydroxytryptamine2A receptor determines effector coupling specificity.

Oksenberg D, Havlik S, Peroutka SJ, Ashkenazi A.

J Neurochem. 1995 Apr;64(4):1440-7.

PMID:
7891070
42.

5-HT receptors: past, present and future.

Peroutka SJ.

Trends Neurosci. 1995 Feb;18(2):68-9. Review. No abstract available.

PMID:
7537413
43.

5-Hydroxytryptamine receptors in vertebrates and invertebrates: why are there so many?

Peroutka SJ.

Neurochem Int. 1994 Dec;25(6):533-6. Review.

PMID:
7894329
44.

Molecular biology of serotonin (5-HT) receptors.

Peroutka SJ.

Synapse. 1994 Nov;18(3):241-60. Review.

PMID:
7855737
45.

Role of neurologists in the pharmaceutical industry.

Peroutka SJ.

West J Med. 1994 Sep;161(3):328-30.

46.

Differential binding of ergot compounds to human versus rat 5-HT2 cortical receptors.

Hagen JD, Pierce PA, Peroutka SJ.

Biol Signals. 1994 Sep-Oct;3(5):223-9.

PMID:
7704103
47.

Pharmacological differentiation of human 5-HT1B and 5-HT1D receptors.

Peroutka SJ.

Biol Signals. 1994 Sep-Oct;3(5):217-22.

PMID:
7704102
48.

The effect of systemically administered recombinant human nerve growth factor in healthy human subjects.

Petty BG, Cornblath DR, Adornato BT, Chaudhry V, Flexner C, Wachsman M, Sinicropi D, Burton LE, Peroutka SJ.

Ann Neurol. 1994 Aug;36(2):244-6.

PMID:
8053664
49.

The molecular evolution of G protein-coupled receptors: focus on 5-hydroxytryptamine receptors.

Peroutka SJ, Howell TA.

Neuropharmacology. 1994 Mar-Apr;33(3-4):319-24.

PMID:
7984268
50.

Supplemental Content

Loading ...
Support Center